Alarming figures.About two million Peruvians suffer from diabetes mellitus, but the most serious thing is that at least half of them do not know that they suffer and suffer from medical complications such as amputation or limb loss, blindness, renal failure, vascular brain accidents and infarcts, among the most common.
These alarming figures occurred in the framework of the Signing of the Peruvian University Cayetano Heredia and the Danish laboratory Novo Nordisk that supports the creation and training of the first master's degree in diabetes and obesity in Peru through the UPCH, with the end with the endto raise knowledge according to international standards to attend more appropriate to the growing population suffering from diabetes.
“Although the official figures of the IDF (International Federation of Diabetes) mention that in Peru there are more than 1,100,000 people suffering from diabetes, specialist doctors agree that this number could really be reaching the two million”Edwin Castro, Novo Nordisk Manager points out.It is for this reason that the Danish company is focused on collaborating on the formation of specialists who are better prepared to treat this pandemic, since there is an increase of 40% of new new cases reported.
It is important to note that Peru will have the first mastery in diabetes and obesity, due to the increase in cases reported.Therefore, Professor Seclén, director of the aforementioned postgraduate degree of the Peruvian University Cayetano Heredia, expressed the importance of this agreement through which students are motivated to compete to obtain the first places who will be able to access to train in places like the Steno centerof diabetes in Denmark, recognized as a center of excellence in research and treatment of this disease.
In this regard, Edwin Castro Manager of Novo Nordisk points out: “We consider this alliance strategic to continue generating preventive culture in the population through training for first level endocrinologists.We want to "change diabetes" in the country and that more and more Peruvians can access an earlier diagnosis and the most advanced treatments. "